Location: Boston, MA
CIK: 0001816307 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $336M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Merus NV | 645,581 | $17.75M | 5.3% | $21.46 | — | EQUITIES | N5749R100 |
| — | Mersana Therapeutics Inc | 6,420,136 | $14.89M | 4.4% | $1.96 | — | EQUITIES | 59045L106 |
| — | Morphic Holding Inc | 500,042 | $14.44M | 4.3% | $34.85 | — | EQUITIES | 61775R105 |
| NUVL | Nuvalent Inc | 193,000 | $14.2M | 4.2% | $61.88 | 0.0% | EQUITIES | 670703107 |
| — | Poseida Therapeutics Inc | 3,705,779 | $12.45M | 3.7% | $3.30 | — | EQUITIES | 73730P108 |
| MGNX | MacroGenics Inc | 1,258,641 | $12.11M | 3.6% | $5.63 | +22.7% | EQUITIES | 556099109 |
| RCKT | Rocket Pharmaceuticals Inc | 382,672 | $11.47M | 3.4% | $22.07 | 0.0% | EQUITIES | 77313F106 |
| MDT | Medtronic PLC | 135,000 | $11.12M | 3.3% | $71.45 | 0.0% | EQUITIES | G5960L103 |
| SNY | Sanofi SA | 220,000 | $10.94M | 3.3% | $49.73 | — | EQUITIES | 80105N105 |
| ORIC | Oric Pharmaceuticals Inc | 1,170,000 | $10.76M | 3.2% | $4.29 | +68.6% | EQUITIES | 68622P109 |
| CLDX | Celldex Therapeutics Inc | 247,215 | $9.805M | 2.9% | $29.41 | 0.0% | EQUITIES | 15117B202 |
| — | Mirati Therapeutics Inc | 150,000 | $8.813M | 2.6% | $40.17 | — | Call | 60468T105 |
| OLMA | Olema Pharmaceuticals Inc | 573,830 | $8.051M | 2.4% | $8.30 | +61.8% | EQUITIES | 68062P106 |
| RYTM | Rhythm Pharmaceuticals Inc | 174,248 | $8.01M | 2.4% | $20.46 | +54.2% | EQUITIES | 76243J105 |
| URGN | Urogen Pharma Ltd | 525,404 | $7.881M | 2.3% | $15.96 | -18.6% | EQUITIES | M96088105 |
| XENE | Xenon Pharmaceuticals Inc | 163,168 | $7.516M | 2.2% | $33.55 | +5.3% | EQUITIES | 98420N105 |
| VCYT | Veracyte Inc | 247,723 | $6.815M | 2.0% | $29.66 | -18.6% | EQUITIES | 92337F107 |
| PRAX | Praxis Precision Medicines Inc | 283,841 | $6.324M | 1.9% | $18.01 | 0.0% | EQUITIES | 74006W207 |
| — | Akero Therapeutics Inc | 249,254 | $5.82M | 1.7% | $23.10 | — | EQUITIES | 00973Y108 |
| PLRX | Pliant Therapeutics Inc | 318,524 | $5.768M | 1.7% | $17.61 | -13.6% | EQUITIES | 729139105 |
| — | Intra-Cellular Therapies Inc | 80,000 | $5.73M | 1.7% | $54.25 | — | EQUITIES | 46116X101 |
| COGT | Cogent Biosciences Inc | 966,748 | $5.684M | 1.7% | $10.13 | -24.4% | EQUITIES | 19240Q201 |
| — | Alpine Immune Sciences Inc | 297,789 | $5.676M | 1.7% | $19.06 | — | EQUITIES | 02083G100 |
| GOSS | Gossamer Bio Inc | 6,130,268 | $5.594M | 1.7% | $1.15 | -35.9% | EQUITIES | 38341P102 |
| ISRG | Intuitive Surgical Inc | 15,808 | $5.333M | 1.6% | $298.09 | 0.0% | EQUITIES | 46120E602 |
| TELA | Tela Bio Inc | 795,080 | $5.263M | 1.6% | $8.49 | -31.9% | EQUITIES | 872381108 |
| BIIB | Biogen Idec Inc | 20,000 | $5.175M | 1.5% | $290.33 | -15.4% | EQUITIES | 09062X103 |
| — | CymaBay Therapeutics Inc | 218,975 | $5.172M | 1.5% | $13.84 | — | EQUITIES | 23257D103 |
| CRBU | Caribou Biosciences Inc | 900,818 | $5.162M | 1.5% | $6.20 | -20.3% | EQUITIES | 142038108 |
| SRRK | Scholar Rock Holding Corp | 270,000 | $5.076M | 1.5% | $12.23 | +1.7% | EQUITIES | 80706P103 |
| PEN | Penumbra Inc | 20,000 | $5.031M | 1.5% | $221.05 | 0.0% | EQUITIES | 70975L107 |
| INSM | Insmed Inc | 155,504 | $4.819M | 1.4% | $26.81 | -3.3% | EQUITIES | 457669307 |
| SRPT | Sarepta Therapeutics Inc | 46,884 | $4.521M | 1.3% | $102.43 | -6.4% | EQUITIES | 803607100 |
| DXCM | DexCom Inc | 31,000 | $3.847M | 1.1% | $102.16 | 0.0% | EQUITIES | 252131107 |
| SLDB | Solid Biosciences Inc | 594,855 | $3.652M | 1.1% | $3.20 | 0.0% | EQUITIES | 83422E204 |
| UTHR | United Therapeutics Corp | 16,360 | $3.597M | 1.1% | $214.96 | +7.2% | EQUITIES | 91307C102 |
| TERN | Terns Pharmaceuticals Inc | 516,999 | $3.355M | 1.0% | $6.55 | -19.3% | EQUITIES | 880881107 |
| CERS | Cerus Corp | 1,499,851 | $3.24M | 1.0% | $4.76 | -65.4% | EQUITIES | 157085101 |
| KOD | Kodiak Sciences Inc | 1,000,000 | $3.04M | 0.9% | $3.53 | -37.0% | EQUITIES | 50015M109 |
| BHVN | Biohaven Ltd | 70,695 | $3.026M | 0.9% | $29.14 | +6.7% | EQUITIES | G1110E107 |
| MLTX | MoonLake Immunotherapeutics | 50,000 | $3.019M | 0.9% | $51.54 | 0.0% | EQUITIES | 61559X104 |
| SLNO | Soleno Therapeutics Inc | 73,665 | $2.965M | 0.9% | $6.05 | +370.0% | EQUITIES | 834203309 |
| — | Evogene Ltd | 3,100,000 | $2.604M | 0.8% | $0.60 | — | EQUITIES | M4119S104 |
| MIRM | Mirum Pharmaceuticals Inc | 80,811 | $2.386M | 0.7% | $22.95 | +31.9% | EQUITIES | 604749101 |
| KALV | KalVista Pharmaceuticals Inc | 180,400 | $2.21M | 0.7% | $7.46 | +21.9% | Call | 483497103 |
| ZURA | Zura Bio Ltd | 462,997 | $2.162M | 0.6% | $6.94 | -27.9% | EQUITIES | G9TY5A101 |
| ANNX | Annexon Inc | 417,429 | $1.895M | 0.6% | $4.26 | -41.9% | EQUITIES | 03589W102 |
| CGEN | Compugen Ltd | 940,000 | $1.861M | 0.6% | $0.88 | -0.5% | EQUITIES | M25722105 |
| ARGX | argenx SE | 4,826 | $1.836M | 0.5% | $380.43 | — | EQUITIES | 04016X101 |
| — | 89bio Inc | 158,719 | $1.773M | 0.5% | $12.71 | — | EQUITIES | 282559103 |
| PMVP | Pmv Pharmaceuticals Inc | 550,000 | $1.705M | 0.5% | $2.65 | 0.0% | EQUITIES | 69353Y103 |
| ALT | Altimmune Inc | 150,000 | $1.688M | 0.5% | $4.18 | 0.0% | EQUITIES | 02155H200 |
| NTLA | Intellia Therapeutics Inc | 54,822 | $1.672M | 0.5% | $52.61 | -45.4% | EQUITIES | 45826J105 |
| BCRX | BioCryst Pharmaceuticals Inc | 248,728 | $1.49M | 0.4% | $10.45 | -44.5% | EQUITIES | 09058V103 |
| KALV | KalVista Pharmaceuticals Inc | 111,734 | $1.369M | 0.4% | $7.46 | +21.9% | EQUITIES | 483497103 |
| — | Molecular Templates Inc | 354,608 | $1.323M | 0.4% | $6.32 | — | EQUITIES | 608550208 |
| TRVI | Trevi Therapeutics Inc | 863,883 | $1.158M | 0.3% | $3.10 | -51.2% | EQUITIES | 89532M101 |
| SDGR | Schrodinger Inc | 31,117 | $1.114M | 0.3% | $25.28 | +14.7% | EQUITIES | 80810D103 |
| VRDN | Viridian Therapeutics Inc | 50,438 | $1.099M | 0.3% | $28.84 | -45.3% | EQUITIES | 92790C104 |
| IMVT | Immunovant Inc | 20,000 | $843K | 0.3% | $36.80 | 0.0% | EQUITIES | 45258J102 |
| — | Mersana Therapeutics Inc | 301,600 | $700K | 0.2% | $1.96 | — | Call | 59045L106 |
| APLS | Apellis Pharmaceuticals Inc | 10,000 | $599K | 0.2% | $50.73 | 0.0% | EQUITIES | 03753U106 |
| — | Karyopharm Therapeutics Inc | 561,955 | $486K | 0.1% | $3.70 | — | EQUITIES | 48576U106 |
| — | Aligos Therapeutics Inc | 668,512 | $444K | 0.1% | $0.86 | — | EQUITIES | 01626L105 |
| RLMD | Relmada Therapeutics Inc | 100,000 | $414K | 0.1% | $2.97 | -0.3% | EQUITIES | 75955J402 |
| RZLT | Rezolute Inc | 157,085 | $156K | 0.0% | $2.06 | -55.5% | EQUITIES | 76200L309 |
| RCKTW | Rocket Pharmaceuticals Inc Wts | 104,828 | $51,366 | 0.0% | $0.11 | — | WARRANTS | 77313F114 |